Tag Archives: Therapeutics

Orbit Subretinal Delivery System for Gene Therapy: Interview with Mike Keane, CTO of Gyroscope Therapeutics

Gyroscope Therapeutics, a retinal gene therapy company, has developed the Orbit subretinal delivery system (SDS). The technology is designed to deliver therapies to the retina without the need for invasive procedures, such as vitrectomies, which involve removing the gel-like substance within the eye, or retinotomies, which involve making a hole in the retina. The company… Read More »

California Blues’ digital therapeutics platform expands member choice

Blue Shield of California and Solera Health have teamed up to offer a new free digital therapeutics platform to BSC members. At the same time, the partnership between BSC and Solera—a company that consolidates highly fragmented programs and services into a single marketplace—aims to hold participating vendors accountable for producing good outcomes. BSC and Solera… Read More »

Amicus Therapeutics receives U.S. approval for Fabry disease drug

(Reuters) – U.S. health regulators on Friday approved Amicus Therapeutics’ Galafold, the first oral therapy to treat Fabry disease, a rare, sometimes fatal condition in which accumulation of fat damages several organs. Galafold, known chemically as migalastat, will be the first new Fabry treatment on the U.S. market in over 15 years, and will compete… Read More »